Semaglutide — Research Peptide (Lyophilised, HPLC ≥99%)

Semaglutide — Research Peptide (Lyophilised, HPLC ≥99%), Research Peptide

Semaglutide is an investigational synthetic GLP-1 analogue research-grade peptide supplied as a sterile lyophilised powder for in-vitro laboratory investigation of GLP-1 receptor binding and signalling pathways. Each batch is characterised by reversed-phase HPLC (≥99%) and identity-confirmed by mass spectrometry; a per-batch Certificate of Analysis is issued with every shipment. Specifications Purity: ≥99% (RP-HPLC) Identity: MS-verified Form: Lyophilised powder, sealed vial Storage: −20 °C, protected from light Manufacturer: Oxford Research Syndicate Ltd Batch / Lot: supplied on COA For in-vitro laboratory research use only. Not a medicinal product. Not for human, veterinary, diagnostic, therapeutic or in-vivo use. Not for resale to the general public.

Usage and Storage

Semaglutide — Research Peptide (Lyophilised, HPLC ≥99%) is supplied as a lyophilised solid to ensure maximum stability and ease of use in research environments. For best results, follow our reconstitution and storage guidelines.

Quality Assurance

Each batch is synthesised through a controlled process and undergoes stringent quality control to meet the high purity and stability standards that researchers require.

Legal and Safety Information

Pondok Peptides provides Semaglutide — Research Peptide (Lyophilised, HPLC ≥99%) strictly for scientific and research use. Our peptides are not designed for human consumption or clinical application.